FDA Inspection
Evaric Pharmaceuticals Inc.Evaric Pharmaceuticals Inc. – FDA Inspection, May 16, 2025
Record Details
This FDA Inspection record concerns Evaric Pharmaceuticals Inc., with an inspection on May 16, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 3909e477-38cc-417f-888c-e683286c4897
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1270045
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- FDCA 582(b)(4)Systems in place to comply with verification requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Evaric Pharmaceuticals Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 29, 2019 | Not classified | New York District Office | |
| February 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Evaric Pharmaceuticals Inc.
- FDA Inspection 1091300 - 2019-05-29
- FDA Inspection 999784 - 2017-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.